Piroxicam selectively inhibits the growth of premalignant and malignant human oral cell lines by limiting their progression through the S phase and reducing the levels of cyclins and AP-1
Haiming Ding, Chunhua Han, Ruth Gibson-D′Ambrosio, Vernon E. Steele, Steven M. D′AmbrosioVolume:
107
Year:
2003
Language:
english
Pages:
7
DOI:
10.1002/ijc.11499
File:
PDF, 180 KB
english, 2003